The Cytel Blog: Perspectives on Enquiry & Evidence

Earlier this summer, we published a series of articles on the need to utilize weighting and prioritization tools in the..

With the cloud computing power that we have today, we can run simulation of 1000s of designs with each design..

Recently we discussed examining clinical development through a Bayesian lens, in honor of Cytel co-founder Nitin Patel..

When developing clinical strategy, applying familiar business principles to the specific requirements of clinical..

When is a study design considered to be optimal? A good design performs well not only under the ideal target scenario..

Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,..

For much of the past three decades, even as methodologies for clinical trial design have advanced and refined, the idea..

The use of wearable and digital technology requires considerations for both drugs and devices regulations, and..

Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics,..